Frontier Wealth Management’s GSK GSK Stock Holding History

Frontier Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,440	Closed	-$250K	–	388
2020 Q4	$250K	Sell	5,440 -578	-10%	-$26.6K	0.02%	320
2020 Q3	$283K	Sell	6,018 -240	-4%	-$12K	0.03%	289
2020 Q2	$319K	Sell	6,258 -13,600	-68%	-$698K	0.03%	269
2020 Q1	$941K	Buy	19,858 +10,840	+120%	+$578K	0.15%	122
2019 Q4	$530K	Sell	9,018 -12,280	-58%	-$683K	0.09%	172
2019 Q3	$1.14M	Sell	21,298 -1,417	-6%	-$72.9K	0.17%	119
2019 Q2	$1.14M	Sell	22,715 -2,957	-12%	-$148K	0.17%	111
2019 Q1	$1.34M	Buy	25,672 +2,039	+9%	+$102K	0.18%	123
2018 Q4	$1.13M	Buy	23,633 +887	+4%	+$43.7K	0.17%	130
2018 Q3	$1.14M	Buy	22,746 +212	+0.9%	+$10.8K	0.11%	140
2018 Q2	$1.14M	Buy	+22,534	New	+$1.13M	0.16%	134
2017 Q1	–	Sell	-4,448	Closed	-$214K	–	409
2016 Q4	$214K	Sell	4,448 -398	-8%	-$19.7K	0.04%	346
2016 Q3	$261K	Buy	+4,846	New	+$266K	0.04%	299
2016 Q1	–	Sell	-4,349	Closed	-$219K	–	359
2015 Q4	$219K	Buy	4,349 +120	+3%	+$6.12K	0.04%	298
2015 Q3	$203K	Buy	+4,229	New	+$220K	0.03%	307

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Frontier Wealth Management's GSK Position: Q1 2021 in Review

Frontier Wealth Management sold out of GSK (GSK) in Q1 2021, closing a stake of 5,440 shares — an estimated $250K sold.

Frontier Wealth Management first reported a position in GSK in Q3 2015 and held it in 15 quarters. The position peaked at $1.34M in Q1 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Frontier Wealth Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Frontier Wealth Management sold 5,440 GSK shares in Q1 2021, an estimated $250K.
Frontier Wealth Management first reported a position in GSK in Q3 2015 and held it in 15 quarters.
Frontier Wealth Management's GSK position peaked at $1.34M in Q1 2019.
774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Frontier Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.